Jankalkowski (Talk | contribs) |
Jankalkowski (Talk | contribs) |
||
Line 34: | Line 34: | ||
<tr> | <tr> | ||
<td scope="row">pET24(+)</th> | <td scope="row">pET24(+)</th> | ||
− | <td> | + | <td>5236 bp</td> |
<td>Kanamycin</td> | <td>Kanamycin</td> | ||
<td>KanR, high-copy-number ColE1/ pMB1/ pBR322/ pUC ori, f1 ori, lacI repressor + lacI promoter, T7 promoter + lac operator, 6xHis, T7 terminator</td> | <td>KanR, high-copy-number ColE1/ pMB1/ pBR322/ pUC ori, f1 ori, lacI repressor + lacI promoter, T7 promoter + lac operator, 6xHis, T7 terminator</td> |
Revision as of 13:05, 21 October 2020
For the in silico design of our experiments for the wetlab we used several different plasmid backbones. Due to Covid-19 we were not able to test any of our constructs in the lab. Therefore, we only planned the shown backbones theoretically. The plasmids would be used for cloning, expression, and genomic integration of our constructs. You can find a list of all plasmids we used for our design and the corresponding parts below.
Name | Size | Resistance | Features | Organism |
---|---|---|---|---|
pET24(+) | 5236 bp | Kanamycin | KanR, high-copy-number ColE1/ pMB1/ pBR322/ pUC ori, f1 ori, lacI repressor + lacI promoter, T7 promoter + lac operator, 6xHis, T7 terminator | E. coli |
pSEVA3b67Rb | Rom-Size | Kanamycin | features | E. coli, B. subtilis |
pJET1.2 | 2974 bp | Ampicillin | AmpR, high-copy-number ColE1/ pMB1/ pBR322/ pUC ori | E. coli |